Anit-IL-23 antibiodies

Details for Australian Patent Application No. 2006283194 (hide)

Owner Eli Lilly and Company

Inventors Beidler, Catherine Brautigam; Bright, Stuart Willis; Dickinson, Craig Duane; Kikly, Kristine Kay; Vasserot, Alain Philippe; Marquis, David Matthew

Agent Spruson & Ferguson

Pub. Number AU-B-2006283194

PCT Pub. Number WO2007/024846

Priority 60/711,336 25.08.05 US; 60/772,355 10.02.06 US

Filing date 23 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 21 October 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/024846 Priority application(s): WO2007/024846

21 October 2010 Application Accepted

  Published as AU-B-2006283194

28 October 2010 Corrigenda

  Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2006283194, under INID (54) correct the title to read Anti-IL-23 Antibodies

17 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283202-Distributed protocol over a wireless connection

2006283189-Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery